These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5135646)

  • 1. [Study of the action of an angioprotector on the vascular fragility of diabetic patients].
    Plauchu M; Amourdedieu J; Rollet J; Jandot V; Kressmann J; Reynaud R
    J Med Lyon; 1971 Apr; 52(206):507-9. PubMed ID: 5135646
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the action of a vascular protector on diabetic vascular fragility].
    Nove-Josserand G; Chirat P; Bussy L; Bonnamour C; Peaud PY; Ortonne JP; Gaillarde B; Plauchu M
    Lyon Med; 1971 Dec; 226(19):791-4. PubMed ID: 5159275
    [No Abstract]   [Full Text] [Related]  

  • 3. [141 MD in the treatment of the capillary fragility in diabetic patients. 60 cases].
    Warembourg H; Jaillard J
    Lille Med; 1970 Apr; 15(4 Suppl 3):603-7. PubMed ID: 5212267
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of calcium dobesilate on capillary fragility in diabetics].
    Beretta P; Sartori F
    Arch Sci Med (Torino); 1977; 134(3):329-36. PubMed ID: 603392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)].
    Freyler H; Sehorst W
    Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications for Dicynone 500 in functional disorders of venous insufficiency].
    Joseph JY
    Lyon Med; 1971 Apr; 225(7):657-9. PubMed ID: 5558876
    [No Abstract]   [Full Text] [Related]  

  • 7. [Capillary fragility in diabetics and its modification by calcium dobesilate].
    Zabel-Langhennig R; Kulle M
    Z Gesamte Inn Med; 1983 Dec; 38(23):633-6. PubMed ID: 6670338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ethamsylate and capillary fragility in diabetics].
    Daubresse JC
    Rev Med Liege; 1971 Aug; 26(15):511-2. PubMed ID: 5562163
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of 2 phenyl-5-7 dioxyacetate of sodium benzo- -pyrone on various hemorrhagic manifestations of diabetic microangiopathy. Preliminary note].
    Pareschi PL
    Minerva Med; 1972 Dec; 63(91):5007-10. PubMed ID: 4644984
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyclonamine (141-E) and capillar fragility in diabetics].
    Cañadell JM
    Rev Clin Esp; 1966 Dec; 103(5):377-80. PubMed ID: 6011982
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of the mandelic ester of 3,5,5-trimethyl-cyclohexanol (Cyclospasmol) on blood flow potentials in peripheral obstructive arteriopathies].
    Russo A; Azzolina P; Biondi M; Montemagno S; Giovinetto A
    Minerva Med; 1969 Aug; 60(69):3110-6. PubMed ID: 5824709
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the treatment of vascular fragility appearing during prolonged anticoagulation].
    Cloetens W; Colin W; Michel J
    Angeiologie; 1967; 19(5):53-66. PubMed ID: 5621974
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium dobesilate as a treatment for capillary fragility in diabetic retinopathy.
    Benarroch IS; de Salama Benarroch AR; Nano H; Perez H; Bisceglia H
    Ophthalmologica; 1974; 168(5):370-5. PubMed ID: 4832044
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cyclonamine in vascular fragility].
    Linquette M; Hubschman B
    Lille Med; 1968 Apr; 13(4):Suppl:506-10. PubMed ID: 5683299
    [No Abstract]   [Full Text] [Related]  

  • 15. Anthocyanins as natural food colorants.
    Timberlake CF; Henry BS
    Prog Clin Biol Res; 1988; 280():107-21. PubMed ID: 3051023
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution of angiosterrometry to the diagnosis of vascular fragility. Its value in control of the therapeutic effectiveness of an angio-protective agent].
    Plauchu M; Bourlier ; Meunier ; Savoye ; Molinie ; Reynaud R
    Lyon Med; 1967 Jul; 218(31):189-96. PubMed ID: 5611644
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new capillary protector].
    Rass Int Clin Ter; 1969 Nov; 49(21):1393-4. PubMed ID: 5405175
    [No Abstract]   [Full Text] [Related]  

  • 18. Capillary fragility and doxium. A controlled clinical trial.
    Rasch R
    Diabetologia; 1973 Dec; 9(6):483-5. PubMed ID: 4773549
    [No Abstract]   [Full Text] [Related]  

  • 19. [Generalized acquired essential telangiectases in a multipara].
    Grupper C; Edelson Y; Bensoussan L
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(3):220-1. PubMed ID: 4642838
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenochrome semicarbazone sulfonic ester and capillary fragility].
    Cristofolini M; Pedrazzoli M
    Clin Ter; 1969 Mar; 48(6):557-62. PubMed ID: 5404654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.